Team DoctorNDTV | Friday November 16, 2001
A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi.
The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...
doctor.ndtv.com